• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项对口服低剂量依曲替酯和外用皮质类固醇治疗的银屑病患者进行的为期三年的随访研究。

A three-year follow-up study of psoriasis patients treated with low dosages of etretinate orally and corticosteroids topically.

作者信息

Polano M K, van der Rhee H J, van der Schroeff J G

出版信息

Acta Derm Venereol. 1982;62(4):361-4.

PMID:6183880
Abstract

Etretinate 0.5 mg/kg body weight combined with 0.1% triamcinolone acetonide and 5% salicylic acid in an O/W cream gave more than 70% improvement in 62% of 75 patients. Of this satisfactorily improved group, at least 41% were still in the same condition after 3 years on a maintenance dose of, on average, 0.3 mg/kg body weight etretinate daily and 20 g weekly of a relatively strong corticosteroid cream. The side effects were acceptable and the convenience for the patients is great as compared with other treatment.

摘要

依曲替酯,剂量为0.5毫克/千克体重,与0.1%曲安奈德和5%水杨酸混合制成水包油乳膏,75例患者中有62%病情改善超过70%。在这一改善效果良好的组中,平均每日服用0.3毫克/千克体重依曲替酯并每周使用20克相对强效的皮质类固醇乳膏进行维持治疗3年后,至少41%的患者病情仍维持原状。与其他治疗方法相比,该治疗方法副作用可接受,且对患者来说极为便利。

相似文献

1
A three-year follow-up study of psoriasis patients treated with low dosages of etretinate orally and corticosteroids topically.一项对口服低剂量依曲替酯和外用皮质类固醇治疗的银屑病患者进行的为期三年的随访研究。
Acta Derm Venereol. 1982;62(4):361-4.
2
Combined treatment of psoriasis with a new aromatic retinoid (Tigason) in low dosage orally and triamcinolone acetonide cream topically: a double-blind trial.低剂量口服新型芳香维甲酸(银屑灵)与外用曲安奈德乳膏联合治疗银屑病:一项双盲试验。
Br J Dermatol. 1980 Feb;102(2):203-12. doi: 10.1111/j.1365-2133.1980.tb05693.x.
3
Oral treatment of keratinizing disorders of skin and mucous membranes with etretinate. Comparative study of 113 patients.
Arch Dermatol. 1982 Feb;118(2):97-100.
4
Methotrexate and etretinate as concurrent therapies in severe psoriasis.甲氨蝶呤和阿维A酯联合治疗重度银屑病。
Arch Dermatol. 1982 Sep;118(9):660-2.
5
[Use of etretinate (RO-10-9359) in intermittent doses and follow-up for 1 year in patients with psoriasis. Final report].[依曲替酯(RO - 10 - 9359)间歇性给药及对银屑病患者随访1年的研究。最终报告]
Med Cutan Ibero Lat Am. 1984;12(1):47-56.
6
Clinical trial of the efficacy and safety of oral etretinate with calcipotriol cream compared with etretinate alone in moderate-severe psoriasis.口服阿维A酯联合卡泊三醇乳膏与单用阿维A酯治疗中重度银屑病的疗效和安全性临床试验
J Eur Acad Dermatol Venereol. 1999 Sep;13(2):91-5.
7
A double-blind comparison of acitretin and etretinate in the treatment of severe psoriasis. Results of a Nordic multicentre study.阿维A酯与阿维A治疗重度银屑病的双盲对照研究。一项北欧多中心研究的结果
Acta Derm Venereol. 1989;69(1):35-40.
8
[Side effects of oral retinoid Ro 10-9359 on the unaffected skin of psoriatic patients: retinoid dermatitis].
Schweiz Med Wochenschr. 1979 Dec 15;109(48):1921-5.
9
Treatment of psoriatic arthropathy with etretinate: a two-year follow-up.依曲替酯治疗银屑病关节炎:两年随访
Acta Derm Venereol. 1986;66(4):321-4.
10
Oral retinoid for psoriasis. A report of a double blind study.口服维甲酸治疗银屑病。一项双盲研究报告。
Acta Derm Venereol Suppl (Stockh). 1979;59(85):133-6.

引用本文的文献

1
Topical corticosteroid-induced skin atrophy: a comprehensive review.外用糖皮质激素引起的皮肤萎缩:综述
Drug Saf. 2015 May;38(5):493-509. doi: 10.1007/s40264-015-0287-7.
2
Etretinate. A review of its pharmacological properties and therapeutic efficacy in psoriasis and other skin disorders.依曲替酯。对其药理特性及在银屑病和其他皮肤病中的治疗效果的综述。
Drugs. 1983 Jul;26(1):9-43. doi: 10.2165/00003495-198326010-00002.
3
Synthetic retinoids in dermatology.皮肤科中的合成类视黄醇
Can Med Assoc J. 1985 May 15;132(10):1129-36.